$303.74 -4.27 (%) Allergan PLC - NYSE

Aug. 31, 2015 | 04:00 PM

Partner Headlines

  1. Moody Lynn & Lieberson Top Buys in Second Quarter

    GuruFocus | Aug. 27, 2015 | 16:42PM EST
  2. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus | Aug. 25, 2015 | 13:37PM EST
  3. Allergan Gedeon Richter Plc. to Present Data from Cariprazine Trials at ECNP Annual Meeting in Amsterdam

    Benzinga | Aug. 25, 2015 | 04:26AM EST
  4. Kelly Lawrence W & Associates' Top Buys of Q2 2015

    GuruFocus | Aug. 24, 2015 | 17:31PM EST
  5. 13F Recap: The Most Popular (And Unpopular) Stocks Of Q2

    Benzinga | Aug. 19, 2015 | 08:48AM EST
  6. Allergan, Google Among Popular Guru Stocks

    GuruFocus | Aug. 18, 2015 | 17:21PM EST
  7. Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical

    Benzinga | Aug. 18, 2015 | 16:33PM EST
  8. A Look At Bill Ackman's Super-Concentrated Equity Portfolio

    Benzinga | Aug. 18, 2015 | 15:51PM EST
  9. John Paulson Betting On Healthcare And Consumer Discretionary Stocks

    Benzinga | Aug. 18, 2015 | 15:11PM EST
  10. M&R Capital Management Buys Allergan in Q2 2015

    GuruFocus | Aug. 17, 2015 | 16:59PM EST
  11. Howard Marks Still Likes Store Capital, Sold Out Of Tata Motors In New 13F

    Benzinga | Aug. 13, 2015 | 16:50PM EST
  12. 3D Systems Upgraded, Netflix Puts Pressure On Viacom

    IBD | Aug. 7, 2015 | 09:13AM EST
  13. Allergan Modestly Tops Views

    IBD | Aug. 6, 2015 | 18:43PM EST
  14. One Capital Management Cuts Stake in General Electric

    GuruFocus | Aug. 6, 2015 | 16:28PM EST
  15. Allergan Q2 Beats, But Generics Sale Clouds Outlook

    IBD | Aug. 6, 2015 | 11:07AM EST
  16. Allergan Q2 Earnings Beat Estimates

    Benzinga | Aug. 6, 2015 | 08:10AM EST
  17. 10 Must Watch Stocks for Today

    Benzinga | Aug. 6, 2015 | 05:02AM EST
  18. Earnings Scheduled For August 6, 2015

    Benzinga | Aug. 6, 2015 | 04:15AM EST
  19. Sucampo hits high on EPS

    IBD | Aug. 5, 2015 | 18:43PM EST
  20. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD | Aug. 5, 2015 | 14:58PM EST
  21. Sucampo Stock Hits High On EPS, But CVS Nixes Drug

    IBD | Aug. 5, 2015 | 12:52PM EST
  22. Allergan Earnings Are On Deck: Here's Why They Should Meet Expectations

    Benzinga | Aug. 5, 2015 | 11:29AM EST
  23. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.

    Benzinga | Aug. 5, 2015 | 09:25AM EST
  24. Top Mutual Funds Pile In Celgene Other Leading Stocks

    IBD | Aug. 4, 2015 | 18:51PM EST
  25. Akorn's

    IBD | Aug. 4, 2015 | 18:41PM EST
  26. 5 Biotechs With Catalysts Coming This Week

    Benzinga | Aug. 3, 2015 | 16:59PM EST
  27. 5 Top Medical Stocks Reporting Earnings This Week

    IBD | Aug. 3, 2015 | 13:05PM EST
  28. Calls Of Note: The Street's Research Moving Stocks This Monday

    Benzinga | Aug. 3, 2015 | 10:24AM EST
  29. Dan Loeb's Favorite Stock Picks

    Benzinga | Aug. 3, 2015 | 08:39AM EST
  30. IBD 50: 10 Top Stocks Reporting Earnings This Week

    IBD | Aug. 1, 2015 | 08:02AM EST
  31. Valeant Missed Out On Botox But Hits With Other Buys

    IBD | Jul. 31, 2015 | 16:03PM EST
  32. Zeltiq Hits New High After Raising Guidance Again

    IBD | Jul. 31, 2015 | 14:06PM EST
  33. Six International Leaders Preparing To Report Results

    IBD | Jul. 30, 2015 | 18:23PM EST
  34. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD | Jul. 29, 2015 | 18:50PM EST
  35. Morgan Stanley Resumes Teva At Overweight, Sees Large EPS Growth Coming

    Benzinga | Jul. 29, 2015 | 09:37AM EST
  36. 5 Stocks With Notable Short-Selling Activity

    Benzinga | Jul. 29, 2015 | 09:12AM EST
  37. RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan

    Benzinga | Jul. 29, 2015 | 08:54AM EST
  38. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD | Jul. 28, 2015 | 20:07PM EST
  39. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD | Jul. 28, 2015 | 14:33PM EST
  40. Stocks In Rebound Mode; Icon, Cadence Break Out

    IBD | Jul. 28, 2015 | 13:36PM EST
  41. Is More M&A On The Way For Large-Cap Biotechs?

    Benzinga | Jul. 28, 2015 | 13:18PM EST
  42. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 13:08PM EST
  43. Can Health Care Sector Continue its Incredible Run?

    FoxBusiness | Jul. 28, 2015 | 12:30PM EST
  44. Teva Still A 'Must-Own' Stock, Worth $86

    Benzinga | Jul. 28, 2015 | 09:15AM EST
  45. Mandel's Lone Pine Takes Stake in Growing Horizon Pharma

    GuruFocus | Jul. 28, 2015 | 02:14AM EST
  46. Teva Prefers Allergan Unit

    IBD | Jul. 27, 2015 | 18:56PM EST
  47. Benzinga's M&A Chatter for Monday July 27, 2015

    Benzinga | Jul. 27, 2015 | 18:39PM EST
  48. Why The $40.5 Billion Acquisition Of Allergan's Generic Business For Teva Is 'Right Deal At The Right Time'

    Benzinga | Jul. 27, 2015 | 16:49PM EST
  49. Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA

    Benzinga | Jul. 27, 2015 | 16:45PM EST
  50. Stocks Fall For Fifth Straight Session On China Woes

    IBD | Jul. 27, 2015 | 16:39PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!